Elevance (ELV) PT Raised to $450 at Cantor Fitzgerald: Medicaid Cost Deterioration Unlikely

July 7, 2026 7:25 AM

Cantor Fitzgerald analyst Sarah James raised the price target on Elevance (NYSE: ELV) to $450.00 (from $400.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found